Companies/US/ZBH

ZIMMER BIOMET HOLDINGS, INC.

Income flow

Annual
ZBH 10-K Income StatementPeriod 2025-12-31Source 10-K
Knees$3BSet$2BHips$2BTechnology And Data Bone Cement And Surgical$666MRevenue$8B+7% Y/YGross profit$6B+5% Y/YCost of revenue$2BOperating profit$1B-15% Y/YOperating expenses$5BNet profit$705M-22% Y/YTax$126MSG&A$3BR&D & other$1B

As-filed revenue segments and annual P&L (gross, opex, tax, net). Layout inspired by SankeyArt finance diagrams.

Revenue mix

2025-12-31 · 10-K · USD
By activity
By activity$8.2B
  • Knees$3.3B40.4%
  • Set$2.2B26.1%
  • Hips$2.1B25.4%
  • Technology And Data Bone Cement And Surgical$666M8.1%
By geography
By geography$16.5B
  • Americas$5.1B31.3%
  • United States$4.8B28.9%
  • Non-US$3.5B21.1%
  • EMEA$1.8B11.1%
  • Asia Pacific$1.3B7.6%

Capital & dividends

YieldTrailing twelve-month dividends as a percent of the current share price (income yield).1.04%5y avgAverage dividend yield over the past five years — a smoother view than the latest print.0.86%Trailing DPSCash dividends paid per share over the last twelve months (dividend per share, trailing).0.96PayoutShare of earnings paid out as dividends. Higher means more income returned; lower leaves more for reinvestment.23.3%Shares outTotal shares currently outstanding (issued and not retired).190.7MFloatShares available to trade — outstanding minus closely held (insiders, strategic holders).190.1M
Upcoming dividend
Ex-dividend
2026-09-30
Next pay
2026-10-30
Last cash
0.24 · 2026-09-30
Stock splits
  1. 103:1002022-03-01

Valuation

Trailing PE 25.1 (2025-12-31)PE trend

Fiscal PE2

PeriodEPSClosePE
2025-12-313.5589.225.1
2024-12-314.43103.7623.4

PE = stored close ÷ as-filed diluted EPS (annual 10-K / 20-F). Not a vendor PE series.